Al-Dhubaibi, Mohammed (2016) Treatment of Mild to Moderate Acne with Conventional versus Two Different Intermittent Doses and Continuous Low-dose of Isotretinoin: A Randomized, Comparative Study. British Journal of Medicine and Medical Research, 13 (3). pp. 1-7. ISSN 22310614
Dhubaibi1332015BJMMR23594.pdf - Published Version
Download (129kB)
Abstract
Background: Oral isotretinoin is a unique drug that affects all four basic pathogenic mechanisms and the most effective systemic drug currently available for treatment of acne vulgaris. In this study, we aimed to assess the efficacy and tolerability of two different intermittent doses and continuous low-dose and to compare them with the conventional dose of isotretinoin in the treatment of mild to moderate acne vulgaris.
Methods: Eighty patients with mild to moderate acne were enrolled and randomized to receive either isotretinoin at 0.5–0.7 mg/kg daily for six months (group A), isotretinoin at 0.5–0.7 mg/kg daily for 1 month, then daily for 1 week out of every 4 weeks for six months (group B), isotretinoin at 0.5–0.7 mg/kg daily for 1 week out of every 4 weeks for six months (group C) or isotretinoin at 0.25–0.4 mg/kg) daily for six months (group D).
Results: Patient satisfaction was highest among group D, followed by group C, then B, and then A with statistically significant differences between groups A and D (P = 0.003) and groups D and B compared to C (P = 0.019).Side effects were more frequent with conventional dose compared with two intermittent doses and continuous low-dose.
Conclusions: This study suggests that, when considering tolerability, efficacy and patient satisfaction, continuous low-dose treatment is most suitable for patients with mild to moderate acne.
Item Type: | Article |
---|---|
Subjects: | AP Academic Press > Medical Science |
Depositing User: | Unnamed user with email support@apacademicpress.com |
Date Deposited: | 22 May 2023 04:54 |
Last Modified: | 02 Oct 2024 06:47 |
URI: | http://info.openarchivespress.com/id/eprint/1308 |